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Alterations in gene expression induced by cyclic mechanical stress
in trabecular meshwork cells
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Purpose: To investigate the changes in gene expression induced by cyclic mechanical stress (CMS) in trabecular
meshwork (TM) cells.
Methods: Human TM cultures from three donors were plated on type I collagen-coated flexible silicone bottom plates
and subjected to 15% stretching, one cycle per second for 6 h. Non-stressed parallel control cultures were incubated under
the same conditions in the absence of CMS. Total RNA from each culture was amplified (1 round of amplification) and
hybridized to Operon Human Oligo Arrays version 3.0 (35 K probes). Differences in gene expression induced by CMS
were analyzed using Genespring 7.2. quantitative polymerase chain reaction (Q-PCR) was used to confirm changes in the
expressions of 12 selected genes. The effects of chemical inhibitors for p38, ERK (extracellular signal-regulated kinase),
JNK (Jun N-terminal kinase), PKA (protein kinase A), PI3K (phosphoinositide 3-kinase), and P2 (purinergic 2) receptors
on the induction of MMP3 (matrix metalloproteinase 3), HSP70 (heat shock protein 70), ECSM1 (endothelial cell specific
molecule 1), BMP2 (bone morphogenetic protein 2), VEGFC (vascular endothelial growth factor C), and IL-8 (interleukin
8) were evaluated in porcine TM cells subjected to the same regime of CMS as that used in human cells.
Results: CMS induced extensive gene expression changes (664 genes, p≤0.05) twofold or higher in cultured TM cells.
Many of these changes were related to extracellular matrix (ECM) synthesis and remodeling including the upregulation
of two metalloproteinases (MMP3 and MMP10). Cytoskeleton and cell adhesion genes were also affected by CMS as well
as genes known to be involved in cellular protection against stress including several members of the HSP70 family.
Inhibition of PI3K/AKT and P2 receptors pathways significantly reduced the induction of MMP3 and IL-8 whereas the
inhibition of the PKA/cAMP pathway decreased ECSM1 and BMP2.
Conclusions: CMS activated many genes that could influence the aqueous humor outflow facility, specifically genes
involved in ECM synthesis and remodeling (e.g. MMPs), cytoskeletal organization, and cell adhesion. Induction of MMP3
has the potential to increase the aqueous humor outflow facility and could be part of a homeostatic mechanism involved
in the maintenance of normal intraocular pressure (IOP) levels. Other observed changes are more likely to be related to
general cellular responses to stress (e.g., HSP70, ECSM1, and BMP2). Although these latter changes may initially help
to repair mechanical damage, some of them such as the induction of BMP2 could eventually increase tissue rigidity and
compromise the ability of the TM to maintain normal levels of outflow resistance.
The trabecular meshwork (TM) and Schlemm’s canal
form the major conventional route for aqueous outflow from
the anterior chamber of the human eye. The TM is also the
site of the abnormal increase in outflow resistance that leads
to  elevated  intraocular  pressure  (IOP)  in  glaucoma  [1-4].
Similar to other tissues in the body, the TM is subjected to
mechanical  forces  that  can  exert  important  effects  on  the
normal  physiology  of  the  tissue  as  well  as  contribute  to
pathological alterations [5,6].
Several studies have demonstrated that the TM responds
to the stretch produced by a static increase in IOP by altering
both its morphology and patterns of gene expression [7-10].
Such changes in gene expression have been proposed to play
a role in restoring normal levels of IOP through homeostatic
influences on aqueous humor outflow facility [7,9].
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However, mechanical stress in the TM in vivo does not
only result from simple static changes in IOP. In vivo, the TM
is constantly subjected to transient spikes of IOP such as those
associated with systole of the cardiac cycle, blinking, and eye
movement [1,11]. In particular, the cardiac cycle leads to
oscillations of IOP potentially in the order of 2.7 mmHg,
which  then  produces  cycles  of  TM  tissue  stretching  and
relaxing [11].
In several cell types, cyclic regimes of mechanical stress
are known to exert different effects from static stretching [5].
Therefore,  it  should  be  expected  that  cyclic  mechanical
stimulation of TM cells might elicit different responses from
those observed after static stretching.
Surprisingly, Ramos and Stamer [12] recently reported
that cyclic IOP in perfused anterior segments of human and
porcine eyes resulted in a significant decrease in outflow
facility. These changes in outflow facility were not associated
with detectable damage to the cells or structures of the outflow
pathway, suggesting that it may result from active cellular
responses to the cyclic mechanical stimulus.
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534A  better  characterization  of  the  cellular  responses  to
cyclic  mechanical  stress  (CMS)  in  the  TM  is  needed  to
understand the influences of the biomechanical environment
on  the  physiologic  function  of  the  conventional  outflow
pathway.
To gain insight into these mechanisms, we investigated
the changes in gene expression induced by cyclic mechanical
stress in cultured TM cells using gene microarrays. We also
analyzed  the  potential  involvement  of  several  regulatory
pathways on these observed changes in gene expression.
METHODS
Cell cultures: Within 48 h post mortem, human trabecular
meshwork (HTM) cell cultures were obtained from cadaver
eyes that did not have any history of eye disease [13]. Tissues
were  manipulated  in  accordance  with  the  Declaration  of
Helsinki. Three HTM primary cell lines (from ages 14, 16,
and 25 year old eyes) were used in these experiments. Porcine
TM (pTM) cells were generated from fresh pig eyes using the
same protocol. Cell cultures were maintained at 37 °C in 5%
CO2  in  media  (low  glucose  Dulbecco’s  Modified  Eagle
Medium  [DMEM]  with  L-glutamine,  110  mg/ml  sodium
pyruvate,  10%  fetal  bovine  serum,  100  µM  non-essential
amino acids, 100 units/ml penicillin, 100 µg/ml streptomycin
sulfate, and 0.25 µg/ml amphotericin B). All the reagents were
obtained from Invitrogen Corporation (Carlsbad, CA).
RNA isolation and quantitative polymerase chain reaction:
HTM  and  pTM  primary  cell  cultures  were  washed  with
phosphate buffered saline (PBS) and immediately submerged
in RNA-later (Ambion Inc., Austin, TX). Total RNA was
isolated using an RNeasy kit (Qiagen Inc., Valencia, CA)
according to the manufacturer’s instructions and then treated
with DNase. RNA yields were measured using RiboGreen
fluorescent dye (Molecular Probes, Eugene, OR). First strand
cDNA was synthesized from total RNA (1 µg) by reverse
transcription  using  oligodT  and  Superscript  II  reverse
transcriptase  (Invitrogen  Corporation)  according  to  the
manufacturer’s instructions. Quantitative polymerase chain
reactions (Q-PCR) were performed in a 20 µl mixture that
contained 1 µl of the cDNA preparation and 1X iQ SYBR
Green  Supermix  (Bio-Rad,  Hercules,  CA),  using  the
following PCR parameters: 95 °C for 5 min followed by 50
cycles of 95 °C for 15 s, 65 °C for 15 s, and 72 °C for 15 s.
The fluorescence threshold value (Ct) was calculated using the
iCycle  system  software  (Bio-Rad,  Hercules,  CA).  The
absence of nonspecific products was confirmed by both the
analysis of the melt curves and by electrophoresis in 3% Super
AcrylAgarose gels. β-Actin (ACTB) was used as an internal
standard of mRNA expression. This gene was selected as a
control because it did not show any significant difference in
expression in the array analysis. The primers used for Q-PCR
amplification are shown in Table 1.
Cyclic mechanical stress application in cell culture: HTM
(passage 3) and pTM (passage 4) cultures were plated on type
I collagen-coated flexible silicone bottom plates (Flexcell,
Hillsborough, NC). One day after confluence, culture medium
was  switched  to  serum-free  DMEM  3  h  before  cyclic
mechanical stress. Cells were stressed for 6 h (15% stretching,
1 cycle/s), using the computer-controlled, vacuum-operated
FX-3000 Flexercell Strain Unit (Flexcell). A frequency of 1
TABLE 1. PRIMERS USED FOR Q-PCR AMPLIFICATION.
Gene Forward Reverse
Human genes
β-Actin 5′-CCTCGCCTTTGCCGATCCG-3′ 5′-GCCGGAGCCGTTGTCGACG-3′
HSP70B' 5′-ACAGGAGCACAGGTAAGGCT-3′ 5′-TTCATGAACCATCCTCTCCA-3′
MMP10 5′-TGCATCAGGCACCAATTTAT-3′ 5′-TGTTGGCTGAGTGAAAGAGC-3′
ECSM1 5′-TTTCTCTCACGGAGCATGAC-3′ 5′-GGCAGCATTCTCTTTCACAA-3′
MMP3 5′-GCCAGGGATTAATGGAGATG-3′ 5′-ATTTCATGAGCAGCAACGAG-3′
Regulator of G protein 20 5′-GAAGATCAGAGGCCCACAAT-3′ 5′-GGCGTTGACTTCTTCCAGAG-3′
BMP2 5′-GGACGCTCTTTCAATGGAC-3′ 5′-ACCATGGTCGACCTTTAGGA-3′
Hyaluronan synthase 5′-CACACAGACAGGCTGAGGAC-3′ 5′-TCCAAAGAGTGTGGTTCCAA-3′
VEGFC 5′-GGATGCTGGAGATGACTCAA-3′ 5′-TTCATCCAGCTCCTTGTTTG-3′
JunB proto-oncogene 5′-CGATCTGCACAAGATGAACC-3′ 5′-GCTGCTGAGGTTGGTGTAAA-3′
Nuclear receptor subfamily 4A 5′-GAAGCTGAGATGCCCTGTATC-3′ 5′-ATGGTGGGCTTGATGAACTC-3′
Basic transcription element 5′-GGCTGTGGGAAAGTCTATGG-3′ 5′-CCGTTCACCTGTATGCACTC-3′
Early growth response 3 5′-GCTGAACTGGGCTGTGTTTA-3′ 5′-ACATGATTTCAGAGCGGATG-3′
Porcine genes
β-Actin 5′-AAGATCAAGATCATCGCGCCTCCA-3′ 5′-TGGAATGCAACTAACAGTCCGCCT-3′
HSP70 5′-CCACCAAGGATGCGGGGGTA-3′ 5′-GCGCTCCCCCTTGCCCGTCC-3′
MMP3 5′-TTTTGCAGTTCGAGAACACG-3′ 5′-TGAAAGAGACCCAGGGAATG-3′
ECSM1 5′-TGTTACCGCACAGTCTCAGG-3′ 5′-TGACAGCTGCAAGTCTGCTT-3′
BMP2 5′-ACCAACCTGGTGTCCAAAAG-3′ 5′-GTCCCCACCGAGGAGTTTAT-3′
VEGFC 5′-TTCCTCTAATGCCGGAGATG-3′ 5′-CACACGAGTTGGGGAAAAGT-3′
IL8 5′-AAACTGGCTGTTGCCTTCTT-3′ 5′-ATTTATGCACTGGCATCGAA-3′
List of all primers used in this study to validate the microarray data by Q-PCR. b-Actin   was used as the normalizing control
gene for all comparisons.
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535cycle/s was selected to mimic cardiac frequency. Since it is
difficult to estimate the amount of stress to which TM cells
are subjected in vivo but IOP can change as much as 15 mmHg
in 10 s [11], we selected 15% stretching because at 1 cycle/s,
it  was  high  enough  to  induce  detectable  changes  in  gene
expression  while  exerting  only  minimal  effects  on  cell
survival for both porcine and human TM cells. Control cells
were cultured under the same conditions, but no mechanical
force was applied.
Gene microarray and data analysis: Total RNA from three
HTM cell cultures stressed or held static were amplified (one
round amplification) and hybridized to Operon Human Oligo
Arrays version 3.0 (35 K probes; Eurofins Operon, Huntsville,
AL) at the Duke University Microarray facility (Durham,
NC). The Human Genome Oligo Set Version 3.0 represents
24,650  genes  and  37,123  gene  transcripts.  Raw  data  was
normalized  and  analyzed  using  GeneSpring  7.2  (Silicon
Genetics,  Wilmington,  DE).  Genes  were  filtered  to  their
intensities in the control channel (control used was Universal
Reference Human RNA from Stratagene, Huntsville, AL).
Raw  data  values  below  100  were  considered  unreliable.
Intensity-dependent normalization was performed per spot
and  per  chip  (LOWESS,  locally  weighted  scatterplot
smoothing). An ANOVA test was performed (p values≤0.05
were  considered  significant)  for  genes  differentially
expressed using the Benjamin and Hochberg False Discovery
Rate correction test.
Cell viability assay: Cell viability was assayed after 6 h of
CMS by measuring lactate dehydrogenase released to the
culture media as a result of plasma membrane damage. The
Cito Tox 96® Non-Radioactive Cytotoxicity assay (Promega,
Madison,  WI)  was  used  to  carry  out  the  measurement
following manufacturer’s instructions.
Inhibitors: Chemical inhibitors for p38 (SB203580), mitogen-
activated protein kinase kinase and extracellular regulated
kinase (MEK/ERK; PD98059), Janus kinase protein (JNK;
SP600125), protein kinase A (PKA; H89), phosphoinositide
3-kinase  (PI3K;  wortmannin),  and  P2  receptors  (suramin)
were all from Sigma (St Louis, MO). The inhibitors were used
at  a  concentration  of  10  µM  1  h  before  and  during  the
stretching.
RESULTS
Changes in gene expression after mechanical stress in human
trabecular  meshwork  cells:  HTM  cells  were  subjected  to
mechanical stress for 6 h to evaluate the effects of CMS on
the  gene  expression  profile.  Gene  array  analysis  showed
statistically significant (p≤0.05) 2.0 fold or higher changes in
664  gene  transcripts.  Out  of  these  664  genes,  349  were
upregulated and 315 were downregulated. The genes most
highly upregulated or downregulated after CMS are shown in
Table 2.
CMS induced changes in the expression of genes that are
known to be involved in cell protection as well as genes that
because of their known function could potentially  influence
aqueous humor outflow facility. Specifically, CMS affected
the expression of genes involved in cellular stress (Table 3)
and  extracellular  matrix  (ECM)  synthesis  and  remodeling
(Table 4) as well as genes known to affect cytoskeleton and
cell adhesion (Table 4 and Table 5).
Numerous stress defense and cell defense genes showed
changes in expression. This group included 14 heat shock and
heat shock related genes (Table 3). Heat shock protein 70 B
(HSP70B')  showed  the  largest  upregulation,  and  other
members of the HSP70 family also showed high levels of
induction. In addition, several metallothioneins (1A, 1B, 1E,
1G,  1H,  and  2A),  angiopoietin-like  4,  and  cluster  of
differentiation (CD) antigens were among the upregulated
genes.
Several genes coding for proteins that can affect the ECM
exhibited expression changes after CMS. Among these, the
upregulation of two metalloproteinases, MMP3 and MMP10,
with levels of induction of 29 and 26 fold, respectively, was
particularly noticeable. Various proteoglycan genes showed
either downregulation or upregulation after CMS. The most
upregulated  was  the  endothelial  cell  specific  molecule-1
(ECSM1 or endocan). Genes associated with proteoglycan
synthesis and degradation such as hyaluronan synthase and
several  sulfotransferases  were  also  upregulated.  Important
ECM structural components such as collagens and laminin
showed a decrease in expression. Other significant changes
related  to  the  ECM  included  the  upregulation  of  growth
factors (fibroblast growth factor [FGF] acidic and vascular
endothelial growth factor C [VEGFC]), bone morphogenetic
proteins (2 and 6), and plasminogen activator tissue (Table 4).
CMS altered the expression of many cytoskeleton and
cell adhesion genes. The most upregulated cytoskeleton gene
was an actin binding protein that is also known to be induced
by  oxidative  stress  (ectodermal-neural  cortex).  The  most
downregulated  gene  was  Arg/Abl-interacting  protein
(ArgBP2), which belongs to a family that regulates both cell
adhesion and cytoskeletal organization (Table 5). Among the
genes involved in cell adhesion, particularly evident was the
increase in expression of integrin beta 6 (Table 6).
The original array data files are available at the Gene
Expression  Omnibus  (GEO)  under  accession  number
GSE14768.
Validation of microarray results by quantitative polymerase
chain reaction: Twelve genes upregulated or downregulated
by more than twofold expression were further analyzed by
quantitative PCR in HTM cells. Although, the precise fold
change values observed by Q-PCR were different from those
in the gene arrays, the results were in general agreement with
the arrays for all the analyzed genes (Table 7). In addition, six
upregulated  genes  (MMP3,  interleukin  8  [IL8],  VEGFC,
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536TABLE 2. GENES WHOSE EXPRESSION WAS FOUND TO CHANGE BY GREATER THAN FIVE FOLD AFTER EXPOSURE TO CMS.
Genes upregulated and downregulated in HTM cells after CMS Fold p value
 accession
number
Heat shock 70 kDa protein 6 (HSP70B') 489.4 0.0206 NM_002155
Protein phosphatase 1, subunit 14C 66.58 2.84E-05 NM_030949
Integrin, beta 6 59.16 0.000405 NM_000888
Regulator of G-protein signaling 20 53.81 0.000828 NM_003702
Chromosome 9 open reading frame 26 (NF-HEV) 40.98 5.60E-05 NM_033439
Endothelial cell-specific molecule 1 33.41 0.000613 NM_007036
Matrix metalloproteinase 3 (stromelysin 1) 29.78 1.13E-05 NM_002422
Matrix metalloproteinase 10 (stromelysin 2) 26.72 0.000597 NM_002425
Nm23-phosphorylated unknown substrate 23.27 1.77E-05 NM_032873
Bone morphogenetic protein 2 20.07 0.000553 NM_001200
Neuronal protein 19.73 0.0002 NM_013259
Hypothetical protein FLJ23657 17.56 0.000366 AK074237
T-cell activation kelch repeat protein 17.12 0.000116 NM_032505
Parathyroid hormone-like hormone 16.73 0.0055 NM_002820
Hypothetical protein FLJ12604 15.98 0.000264 NM_024621
Kruppel-like factor 7 (ubiquitous) 15.62 0.000214 BC012919
Fibroblast growth factor 1 (acidic) 13.75 0.00479 NM_000800
Hypothetical protein FLJ13391 12.28 5.88E-05 NM_032181
Galanin 10.68 0.000155 NM_015973
ATPase family, AAA domain containing 3B 10.64 1.38E-05 NM_031921
Pentaxin-related gene 9.761 0.00016 NM_002852
Polymerase (RNA) III polypeptide D 9.255 4.25E-06 NM_001722
Metallothionein 1G 8.385 0.0134 BC020757
Hypothetical protein MGC11324 8.315 0.00094 NM_032717
Heat shock 70 kDa protein 1B 8.117 0.000324 NM_005346
Potassium voltage-gated channel, member 4 7.964 6.90E-05 NM_004978
Nucleoside phosphorylase 7.604 7.38E-05 NM_000270
Protein phosphatase 1, subunit 15A 7.104 0.000387 NM_014330
Regulator of G-protein signaling 17 6.969 0.000364 NM_012419
Carbohydrate (chondroitin 4) sulfotransferase 11 6.801 0.00106 NM_018413
ADP-ribosylation factor-like 7 6.475 0.000369 NM_005737
Dickkopf homolog 1 (Xenopus laevis) 6.464 0.000163 NM_012242
Solute carrier family 17, member 1 6.442 0.00549 NM_005074
BTB (POZ) domain containing 11 6.193 5.74E-05 NM_152322
Thymic stromal lymphopoietin 6.189 0.00254 NM_033035
Mitogen-activated protein kinase kinase 4 6.099 0.00378 NM_003010
Heat shock 105 kDa/110 kDa protein 1 5.997 0.000789 NM_006644
Chemokine (C-C motif) ligand 7 5.941 0.00053 NM_006273
Vascular endothelial growth factor C 5.917 7.05E-05 NM_005429
GTPase activating Rap/RanGAP domain-like 4 5.888 0.00123 AB028962
Iduronidase, alpha-L- 5.829 7.76E-05 NM_000203
T-box 3 (ulnar mammary syndrome) 5.765 6.16E-05 NM_016569
Hyaluronan synthase 2 5.388 0.00474 NM_005328
Heparan sulfate 3-O-sulfotransferase 1 5.377 0.00618 NM_005114
Bone morphogenetic protein 6 5.079 0.00223 NM_001718
Myosin X 5.073 3.50E-05 AB018342
Integrin, alpha 2 5.06 0.0112 NM_002203
Basic transcription element binding protein 1 -13.88 0.0022 NM_001206
Contactin 3 (plasmacytoma associated) -13.41 0.00967 AB040929
Nuclear receptor subfamily 4, group A, member 2 -13.28 0.000121 NM_006186
Nuclear receptor subfamily 4, group A, member 1 -12.58 0.000702 NM_173158
Chromosome 20 open reading frame 129 -10.39 0.000593 NM_030919
Distal-less homeo box 2 -9.82 2.50E-05 NM_004405
Neuropeptide Y receptor Y1 -9.366 0.00977 NM_000909
Early growth response 3 -8.314 0.000761 NM_004430
FBJ murine osteosarcoma viral oncogene homolog B -8.036 0.000207 NM_006732
Chromosome 2 open reading frame 11 -7.839 0.00422 NM_144629
B-cell CLL/lymphoma 3 -7.259 0.00165 NM_005178
Chromosome 6 open reading frame 111 -7.021 0.00265 NM_032870
Tumor necrosis factor superfamily, member 10 -6.621 0.000944 NM_003810
F-box protein 32 -6.561 0.00181 NM_058229
Nuclear receptor subfamily 4, group A, member 3 -6.488 0.000476 NM_173200
Solute carrier family 40, member 1 -6.414 0.000916 NM_014585
Phosphodiesterase 5A, cGMP-specific -6.261 0.00289 NM_001083
Zinc finger protein 36, C3H type-like 2 -5.684 0.000817 NM_006887
Myeloid/lymphoid or mixed-lineage leukemia -5.466 0.00544 NM_004529
KIAA1199 -5.371 0.00384 AB033025
TGFB inducible early growth response -5.246 0.000796 NM_005655
Columns show the gene name, the fold expression change determined by microarray analysis, the calculated p value, where
p<0.05 was considered to be statistically significant, and the GeneBank accession number.
Molecular Vision 2009; 15:534-544 <http://www.molvis.org/molvis/v15/a54> © 2009 Molecular Vision
537
GenBankHSP70, bone morphogenetic protein 2 [BMP2], and ECSM1)
were validated in pTM cells to further analyze the effect of
inhibitors on gene expression during mechanical stress.
Cell viability: After CMS (6 h -15% stretching, one cycle/s),
both HTM and pTM cells showed only a small decrease in
viability (5% and 7%, respectively) when compared to cells
in the same conditions without stress.
Effect of inhibitors on gene expression during mechanical
stress: Chemical inhibitors were used to analyze the effect of
the  MAP  kinase  pathways  (p38,  ERK,  JNK),
phosphoinositide 3-kinase (PI3) pathway, PKA pathway, and
P2Y receptor signaling pathway on gene expression changes
induced by mechanical stress. We evaluated the effects of
these inhibitors upon the induction of some ECM regulator/
TABLE 3. CMS-INDUCED CHANGES IN HTM CELLS STRESS/DEFENSE GENES.
Stress induced genes up and down regulated in HTM cells Fold p value
GenBank
 number
Heat shock 70 kDa protein 6 (HSP70B') 489.4 0.0206 NM_002155
Pentaxin-related gene, rapidly induced by IL-1 beta 9.761 0.00016 NM_002852
Metallothionein 1G 8.385 0.0134 BC020757
Heat shock 70 kDa protein 1B 8.117 0.000324 NM_005346
Protein phosphatase 1, regulatory (inhibitor) subunit 15A 7.104 0.000387 NM_014330
Heat shock 105 kDa/110 kDa protein 1 5.997 0.000789 NM_006644
Heat shock 70 kDa protein 8 4.551 0.00105 NM_006597
Heat shock 70 kDa protein 5 (glucose-regulated protein, 78 kDa) 4.268 0.0309 NM_005347
Serum/glucocorticoid regulated kinase 4.265 0.00277 NM_005627
Phosphoprotein with glycosphingolipid-enriched microdomains 4.097 0.000293 NM_018440
DnaJ (Hsp40) homolog, subfamily A, member 1 3.838 0.00456 NM_001539
DnaJ (Hsp40) homolog, subfamily B, member 1 3.79 0.000307 NM_006145
Metallothionein 1B (functional) 3.286 0.00116 NM_005947
BCL2-associated athanogene 3 3.18 0.00513 NM_004281
Metallothionein 2A 3.164 0.0026 NM_005953
similar to Escherichia coli DnaJ, but lacks a J-domain 3.108 0.000794 AF395440
UL16 binding protein 2 3.104 0.0157 NM_025217
Metallothionein 1H 3.086 0.00131 NM_005951
Stress-induced-phosphoprotein 1 3.016 0.000709 NM_006819
Metallothionein 1E (functional) 2.92 0.0407 AF495759
Protein phosphatase 1, regulatory subunit 10 2.789 0.0343 NM_002714
Angiopoietin-like 4 2.753 0.00858 NM_139314
DnaJ (Hsp40) homolog, subfamily B, member 4 2.742 0.0108 NM_007034
Heat shock 90 kDa protein 1, alpha-like 3 2.616 0.00257 M30627
Metallothionein 1A (functional) 2.546 0.00823 BC029475
Heat shock 90 kDa protein 1, alpha 2.446 0.00395 NM_005348
Chaperonin containing TCP1, subunit 6A (zeta 1) 2.33 0.00148 NM_001762
Heat shock 90 kDa protein 1, beta 2.306 1.09E-05 NM_007355
Fas (TNFRSF6)-associated via death domain 2.285 0.0025 NM_003824
Heat shock 70 kDa protein 9B (mortalin-2) 2.248 0.00138 NM_004134
Px19-like protein 2.137 0.00876 NM_013237
AHA1 2.133 0.00863 NM_012111
Nuclear receptor subfamily 4, group A, member 2 -13.28 0.000121 NM_006186
Tumor necrosis factor (ligand) superfamily, member 10 -6.621 0.000944 NM_003810
Angiopoietin-like factor -4.358 0.0103 NM_021146
synonyms: G10P1, IFI56, IFI-56, IFNAI1, RNM561, GARG-16; -3.888 0.00272 NM_001548
Hypoxia-inducible protein 2 -3.398 0.00368 NM_013332
Interferon regulatory factor 1 -3.185 0.00155 NM_002198
Chemokine-like receptor 1 -3.145 0.00408 NM_004072
Bradykinin receptor B2 -2.916 0.00242 NM_000623
Histone deacetylase 5 -2.88 0.00044 NM_005474
Calcium modulating ligand -2.562 4.70E-05 NM_001745
Interferon gamma receptor 2 (interferon gamma transducer 1) -2.546 0.000401 NM_005534
Zinc finger protein 179 -2.425 0.0108 NM_007148
Heat shock transcription factor 2 -2.42 6.74E-07 NM_004506
Oxidation resistance 1 -2.373 0.0148 BC032710
Nuclear factor, interleukin 3 regulated -2.166 0.000751 NM_005384
Heat shock 27 kDa protein 2 -2.125 0.0199 NM_001541
Collagen, type IV, alpha 3 binding protein -2.124 0.00719 NM_005713
Prostaglandin-endoperoxide synthase 2 -2.008 0.0142 NM_000963
Genes functionally relevant to cell stress/defense responses that were significantly up- or down-regulated more than two fold
after  CMS in TM cells. Columns show the gene name, the fold expression change determined by microarray analysis, the
calculated p value, where p<0.05 was considered to be statistically significant, and the GeneBank accession number.
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accessionmodifier  genes  (MMP3,  BMP2,  and  ECSM1),  the  most
upregulated stress response gene on the array (HSP70B’), one
inflammatory response gene (IL8), and one growth factor gene
(VEGFC).
The inhibition of the MAP kinase pathways (p38, JNK,
and ERK) resulted in the CMS-mediated induction of the heat
shock protein 70 (HSP70), but this effect was only statistically
significant for the inhibition of ERK. The induction of IL8 was
enhanced with the JNK inhibitor. ERK and JNK inhibitors
decreased  the  level  of  induction  of  IL8  and  MMP3,
respectively. PKA pathway inhibition reduced the induction
of IL8, ECSM1, BMP2, and VEGFC. Inhibition of the PI3
pathway affected the induction of MMP3 and IL8. The P2Y
receptor signaling pathway inhibitor, suramin, also decreased
the induction of MMP3 and IL8. Treatment with suramin also
resulted in the induction of HSP70 (Figure 1A-F).
DISCUSSION
Our results document that CMS induced an intricate response
in cultured TM cells with extensive gene expression changes.
Some of these changes could participate in outflow regulator
mechanisms and could be part of a homeostatic mechanism to
maintain  normal  IOP  levels.  Others  probably  serve  to
maintain cellular integrity from mechanical stress.
Although some changes such as the induction of MMP3
have been reported in other models of mechanical stress [7],
the overall pattern of gene expression associated with cyclic
mechanical stress was clearly different from that reported in
similar experiments using static stress. One factor that could
potentially lead to such differences is the cell type used in the
experiments. While Vittal et al. [9] used porcine TM cells, our
study was conducted using human TM cells. However, Q-
PCR analyses of six genes upregulated in human cells were
also upregulated in porcine cells, suggesting that the responses
TABLE 4. EXTRACELLULAR MATRIX CHANGES IN GENE EXPRESSION AFTER CMS IN HTM CELLS.
Gene
GenBank
accession 
number
ECM genes upregulated after CMS
ECM regulators/modifiers
Matrix metalloproteinase 3 (stromelysin 1, progelatinase) 29.78 1.13E-05 NM_002422
Matrix metalloproteinase 10 (stromelysin 2) 26.72 0.000597 NM_002425
Bone morphogenetic protein 2 20.07 0.000553 NM_001200
Fibroblast growth factor 1 (acidic) 13.75 0.00479 NM_000800
Carbohydrate (chondroitin 4) sulfotransferase 11 6.801 0.00106 NM_018413
Vascular endothelial growth factor C 5.917 7.05E-05 NM_005429
Hyaluronan synthase 2 5.388 0.00474 NM_005328
Heparan sulfate (glucosamine) 3-O-sulfotransferase 1 5.377 0.00618 NM_005114
Bone morphogenetic protein 6 5.079 0.00223 NM_001718
Carbohydrate (N-acetylglucosamine-6-O) sulfotransferase 2 4.423 0.000172 NM_004267
Heparan sulfate (glucosamine) 3-O-sulfotransferase 3A1 4.329 1.13E05 NM_006042
Tumor necrosis factor, alpha-induced protein 6 4.082 0.00033 NM_007115
Plasminogen activator, tissue 3.236 0.00284 NM_000931
Tissue factor pathway inhibitor 2 2.74 0.00486 NM_006528
Procollagen C-endopeptidase enhancer 2 2.594 0.00373 NM_013363
A disintegrin-like and metalloprotease with thrombospondin type 1 motif, 1 2.081 0.0285 NM_006988
Proteoglycans
Endothelial cell-specific molecule 1 33.41 0.000613 NM_007036
Syndecan 1 2.802 0.00156 NM_002997
Chondroitin sulfate proteoglycan 4 (melanoma-associated) 4.376 0.000852 NM_001897
ECM genes downregulated after CMS
ECM regulators/modifiers
Transforming growth factor, beta receptor III (betaglycan, 300 kDa) -2.864 0.00214 NM_003243
Thrombospondin 1 -2.883 0.0163 NM_003246
A disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 5 (aggrecanase-2) -2.771 0.0196 NM_007038
Transforming growth factor, beta 3 -2.64 0.00823 NM_003239
Bone morphogenetic protein receptor, type IA -2.494 0.0243 NM_004329
Sulfatase 2 -2.336 0.00141 AB033073
Sulfatase 1 -2.283 0.0124 AB029000
Lysyl oxidase-like 4 -2.144 0.000569 NM_032211
Proteoglycans
Glypican 4 -3.08 0.00368 NM_001448
Osteoglycin (osteoinductive factor, mimecan) -2.297 0.0105 NM_033014
Matrix proteins
Collagen, type VIII, alpha 1 -2.594 0.0103 NM_001850
Laminin, beta 1 -2.443 0.0023 NM_002291
Collagen, type IV, alpha 3 (Goodpasture antigen) binding protein -2.124 0.00719 NM_005713
Genes associated with ECM that were significantly up- or down-regulated more than two fold after CMS in TM cells. Columns
show  the gene name, the fold expression change determined by microarray analysis, the calculated p value, where p<0.05 was
considered to be statistically significant, and the GeneBank accession number.
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Fold p valuein these two species may be similar. Therefore, it appears more
likely that the type of stress and the specific experimental
conditions could play a more relevant role in our observed
results.
Some of the more prominent changes in gene expression
induced by cyclic mechanical stress affected genes involved
in  cellular  protection  against  different  types  of  stress.  In
particular, these changes included upregulation of the HSP70
family.  This  family  of  HSPs  comprises  several  highly
evolutionary  conserved  proteins  with  different  levels  of
inducibility in response to metabolic stress that are known to
provide  cytoprotection  to  cells,  making  them  resistant  to
otherwise lethal levels of stress. HSP70 proteins maintain cell
survival  through  the  regulation  of  multiple  steps  within
apoptotic  pathways  (i.e.  stress  activated  protein  kinase
[SAPK] and JNK), and they are also believed to regulate key
upstream mediators of apoptosis including oxidative stress
and Ca2+ overload. The HSP70 family member exhibiting
higher  levels  of  mRNA  induction  in  our  model  was
HSP70B’, which is characterized by tight regulation and high
inducibility. This protein is transiently induced in response to
stress and then rapidly degraded by the proteasome system
[14].
The  observed  upregulation  of  genes  such  as  ECSM1
(endocan) and VEGFC could potentially be associated with
the mitogenic effects that mechanical stress produces in some
other  cell  types  [15].  ECSM1  is  a  dermatan  sulfate
proteoglycan  that  promotes  mitogenic  activity  through
interaction  with  hepatocyte  growth  factor/scatter  during
embryonic development and tissue regeneration [16]. The
VEGF family of proteins can also exert mitogenic responses
and is implicated in embryogenesis and tissue regeneration
[17,18].  VEGFC  has  been  specifically  determined  to  be
required for the development of the vascular and lymphatic
systems [19]. The activation of mitogenic responses by CMS
in  the  TM  together  with  the  induction  of  protective
mechanisms  (e.g.,  HSP70)  could  help  to  explain  the
observation that in organ culture, the TM did not show a net
cell loss but rather an increase in cellularity after CMS [12].
Cyclic  mechanical  stress  induced  changes  in  a  large
number of genes that are known to affect the outflow facility
such  as  those  influencing  the  composition  of  the  ECM,
cellular cytoskeleton, and cell adhesion. However, some of
these changes might be expected to exert contradictory effects
in outflow facility. For instance, while the relatively large
induction observed in MMP3 would be expected to increase
aqueous  humor  outflow  facility  [20],  the  upregulation  of
BMP2  would  be  more  likely  to  decrease  outflow  facility
[21]. The induction of some MMPs by mechanical stress has
been hypothesized to be part of a homeostatic response aimed
TABLE 5. CMS-INDUCED CHANGES IN THE EXPRESSION OF CYTOSKELETON-RELATED GENES.
Cytoskeleton genes upregulated or downregulated in HTM after CMS
Gene
GenBank
accession
number
Ectodermal-neural cortex (with BTB-like domain) 4.998 0.0015 NM_003633
Tubulin, beta, 4 4.489 0.00178 NM_006086
Myosin IXB 3.572 0.000919 NM_004145
Actin related protein 2/3 complex, subunit 5-like 3.519 4.30E-05 NM_030978
Leucine rich repeat (in FLII) interacting protein 1 3.016 0.00186 NM_004735
Syndecan 1 2.802 0.00156 NM_002997
Chromosome 14 open reading frame 31 2.672 0.00977 NM_152330
Kinesin family member 21A 2.588 0.000145 AK000059
Tubulin, beta polypeptide 2.388 0.00293 NM_001069
Leucine rich repeat (in FLII) interacting protein 1 2.212 0.00923 NM_004735
Filamin C, gamma (actin binding protein 280) 2.205 0.00172 NM_001458
Paxillin 2.168 0.00754 NM_002859
Molecule interacting with Rab13 2.153 0.00962 AB051455
Tropomyosin 3 2.126 0.0175 AK092712
Tubulin beta MGC4083 2.119 0.00802 NM_032525
Tubulin alpha 6 2.073 0.000692 NM_032704
Arg/Abl-interacting protein ArgBP2 -4.37 0.000424 NM_021069
Ankyrin repeat, family A (RFXANK-like), 2 -3.24 0.0035 NM_023039
Protein kinase C and casein kinase substrate in neurons 3 -2.913 0.00147 NM_016223
A kinase (PRKA) anchor protein (yotiao) 9 -2.604 0.00434 NM_147185
Syntrophin, beta 2 -2.415 0.00777 NM_006750
Profilin 2 -2.058 0.00371 NM_002628
Downregulated in ovarian cancer 1 -2.036 0.0402 NM_014890
Cytoskeleton related genes that were significantly up- or down-regulated more than two fold after CMS in TM cells. Columns
show  the gene name, the fold expression change determined by microarray analysis, the calculated p value, where p<0.05 was
considered to be statistically significant, and the GeneBank accession number.
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Fold p valueat increasing outflow facility after an increase in IOP [10]. On
the other hand, BMP2 have been shown to increase ECM
deposition,  and  BMP2  activity  in  HTM  cells  has  been
proposed to contribute to outflow resistance by the induction
of osteogenic factors during aging and glaucoma [21-23].
In  our  model,  CMS  elicits  responses  that  could
potentially  increase  outflow  facility  together  with  other
responses that are associated with the need to maintain tissue
integrity in the presence of mechanical forces. While the first
set of responses may help to prevent abnormal elevations of
IOP,  the  second  could  potentially  contribute  to  increased
rigidity of the TM over time and lead to increased outflow
resistance.  A  similar  combination  of  homeostatic  and
pathogenic effects induced by mechanical stress have been
well  documented  in  other  tissues  including  the  vascular
system [24-26].
To gain insight into the regulatory mechanisms governing
the observed responses to CMS, we analyzed the effects of the
inhibition of several regulatory pathways on the induction of
six  relevant  genes  upregulated  after  CMS  (HSP70B’,
TABLE 6. CMS-INDUCED CHANGES IN CELL ADHESION GENES.
Cell adhesion genes upregulated and downregulated in HTM after CMS
Gene
GenBank
accession
number
Integrin, beta 6 59.16 0.000405 NM_000888
Integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) 5.06 0.0112 NM_002203
Chondroitin sulfate proteoglycan 4 (melanoma-associated) 4.376 0.000852 NM_001897
Tumor necrosis factor, alpha-induced protein 6 4.082 0.00033 NM_007115
Leupaxin 3.449 0.000212 NM_004811
Bystin-like 2.625 0.000981 NM_004053
Integrin, alpha 5 (fibronectin receptor, alpha polypeptide) 2.554 0.00151 NM_002205
Protein tyrosine phosphatase, non-receptor type substrate 1 2.38 0.00252 NM_080792
Integrin-linked kinase-associated serine/threonine phosphatase 2C 2.107 0.00141 NM_030768
A disintegrin-like and metalloprotease with thrombospondin type 1 motif, 1 2.081 0.0285 NM_006988
Chemokine (C-X3-C motif) ligand 1 -3.068 0.000683 NM_002996
Thrombospondin 1 -2.883 0.0163 NM_003246
Hyaluronan synthase 1 -2.654 0.00277 NM_001523
Collagen, type VIII, alpha 1 -2.594 0.0103 NM_001850
Plakophilin 4 -2.443 0.0446 NM_003628
Laminin, beta 1 -2.443 0.0023 NM_002291
Discoidin domain receptor family, member 2 -2.306 0.00879 NM_006182
Integrin, beta-like 1 (with EGF-like repeat domains) -2.137 0.012 AB008375
Cadherin 11, type 2, OB-cadherin (osteoblast) -2.04 0.00555 NM_033664
Genes involved in cell adhesion that were significantly up- or down-regulated more than two fold after CMS in TM cells.
Columns show the gene name, the fold expression change determined by microarray analysis, the calculated p value, where
p<0.05 was considered to be statistically significant, and the GeneBank accession number.
TABLE 7. COMPARISON OF FOLD CHANGES BETWEEN ARRAYS AND Q-PCR AFTER CMS IN HTM CELLS.
Gene Q–PCR fold p value Array fold p value
HSP70B' 200.81 6.35E-05 489.4 0.0206
ECSM1 70.92 1.07E-04 33.41 0.000613
MMP3 44.67 1.32E-04 29.78 1.13E-05
Hyaluronan Synthase 16.57 4.85E-04 5.38 0.00474
BMP2 38.87 7.98E-05 20.07 0.000553
Reg. G protein 20 30.76 3.33E-05 53.81 0.000828
VEGFC 4.65 0.00167 5.92 7.05E-05
MMP10 255.31 8.90E-05 26.77 0.0138
NRFFa4a1 -258.07 5.35E-04 −12.58 0.000121
EGR3 -47.5 5.99E-05 −8.31 0.000761
BTEbp-1 -52.14 1.18E-04 −13.88 0.0022
JunB protooncogene -41.66 1.18E-04 −4.67 0.00183
Genes whose expression changes after CMS was validated by Q-PCR. Columns show gene name, fold of expression change
after CMS determined by Q-PCR analysis, the p-value for Q-PCR analysis calculated using the ANOVA test for the differences
in means between the normalized CT values in stretched cells versus non-stretched controls, fold expression change determined
by microarray analysis, and their corresponding p-value.
Molecular Vision 2009; 15:534-544 <http://www.molvis.org/molvis/v15/a54> © 2009 Molecular Vision
541
Fold p valueVEGFC,  MMP3,  BMP2,  ECSM1,  and  IL8).  Since  the
activation  of  inflammatory  cytokines  has  been  previously
reported  as  a  potentially  important  factor  associated  with
CMS  [13,27,28],  we  also  evaluated  the  effects  of  these
inhibitors  on  the  expression  of  IL-8,  which  was  the
inflammatory cytokine most upregulated in our model.
MAPK and cytokines have previously been reported to
be affected by mechanical stress and to induce MMPs in the
TM [8,13,29,30]. Our model supports the involvement of
ERK in the induction of IL8 and JNK in the induction of
MMP3. These two pathways may also have an inhibitory
effect in the induction of HSP70. However, general MAPK
inhibitors do not provide information about specific isoforms
of the different MAPKs, which may play different roles. More
specific analysis will be necessary to clarify the role of the
MAPK isoforms in the responses to CMS in the TM. The role
of PI3K/AKT and P2 receptors in the induction of MMP3 and
IL8 but not in other responses associated with tissue damage
and  regeneration,  (e.g.,  ECSM1,  VEGFC,  and  BMP2)
suggests that PI3K/AKT and P2 receptors could potentially
play a contributing role to homeostatic responses aimed at
lowering IOP. Protective responses aimed at preventing tissue
damage and regeneration such as the induction of ECSM1 and
BMP2  could  potentially  be  induced  by  the  PKA/cAMP
pathway.
All together, our results show that TM cells exposed to
CMS manifest extensive changes in gene expression. Some
of these changes, such as the upregulation of MMP3, have the
Figure 1. Effects of inhibition of p38, MEK/ERK, JNK, PKA, PI3K, and P2 receptor pathways on the upregulation of six genes induced by
CMS. Porcine TM cells were subjected to CMS (15%/1 hrz) for 6 h in the presence or absence of the following inhibitors SB203580 (A; p38),
PD98059 (B; MEK/ERK), SP600125 (C; JNK), H89 (D; PKA), wortmannin (E; PI3K), and suramin (F; P2 receptors). The effects of these
inhibitors on the upregulation of six genes (HSP70, MMP3, IL8, ECSM1, BMP2, and VEGFC) induced by CMS was evaluated by Q-PCR.
Data represents the fold of induction for each gene in the absence or presence of the respective inhibitor (10 µM; n=5). An asterisk indicates
that p is less than or equal to 0.05 using a paired Student’s t test.
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homeostatic  mechanism  involved  in  the  maintenance  of
normal IOP levels. Other changes are more likely to be related
to protective responses aimed at preventing cell and tissue
damage (e.g., HSP70, ECSM1, and BMP2). Our results also
show that several regulatory pathways may contribute to the
diverse responses induced by CMS. The relative contribution
of each of these pathways to the gene expression changes
induced by mechanical stress may depend on the specific
experimental model, which could help explain the variation
in results obtained using different models. It is also possible
that  most  in  vitro  models  may  not  reflect  accurately  the
balance between responses associated with tissue protection
and those involved in the modulation of outflow facility.
In conclusion, the effects of CMS on TM cells seem to
include a complex set of responses. While some of these
responses may contribute to an increase in outflow facility,
others that are perhaps aimed at preserving tissue integrity
from  mechanical  damage  may  have  opposite  effects  on
outflow facility. Since the TM is subjected to CMS in vivo,
elucidating  the  mechanisms  that  protect  the  cells  against
mechanical  damage  and  those  induced  in  outflow  facility
homeostasis may provide important insight into both normal
and pathophysiological outflow function.
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